Search
Patexia Research
Case number 3:19-cv-08233

VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. MYLAN PHARMACEUTICALS INC. et al > Documents

Date Field Doc. No.Description (Pages)
Nov 8, 2022 1 Complaint* (1)
Mar 25, 2021 13 Order (5)
Docket Text: STIPULATION AND ORDER dismissing Civil Action No. 18-14305, Civil Action No. 19-8233, and Civil Action No. 20-2749 without prejudice. Signed by Judge Brian R. Martinotti on 03/25/2021. (jdb)
Apr 15, 2019 N/A Terminated Case (0)
Docket Text: ***Civil Case Terminated. (mps)
Apr 15, 2019 12 Order (7)
Docket Text: ORDER CONSOLIDATING CASES FOR ALL PURPOSES. Civil Action No. 18-13635 shall be the Lead Case and effective upon entry of this order, all filings in the Consolidated Actions are to be made only in Civil Action No. 18-13635. Signed by Judge Peter G. Sheridan on 4/15/2019. (mmh)
Mar 21, 2019 N/A Pretrial Conference - Initial (0)
Docket Text: Text Minute Entry for proceedings held before Magistrate Judge Lois H. Goodman: Initial Pretrial Conference held on 3/21/2019 via Conference Call. (if, )
Mar 19, 2019 9 Notice of Appearance (2)
Docket Text: NOTICE of Appearance by ARNOLD B. CALMANN on behalf of MYLAN INC., MYLAN LABORATORIES LTD., MYLAN PHARMACEUTICALS INC. (CALMANN, ARNOLD)
Mar 19, 2019 10 Notice of Appearance (2)
Docket Text: NOTICE of Appearance by JEFFREY S. SOOS on behalf of MYLAN INC., MYLAN LABORATORIES LTD., MYLAN PHARMACEUTICALS INC. (SOOS, JEFFREY)
Mar 19, 2019 11 Notice of Appearance (2)
Docket Text: NOTICE of Appearance by KATHERINE ANN ESCANLAR on behalf of MYLAN INC., MYLAN LABORATORIES LTD., MYLAN PHARMACEUTICALS INC. (ESCANLAR, KATHERINE)
Mar 18, 2019 8 Letter (1)
Mar 18, 2019 8 Text of Proposed Order (4)
Mar 18, 2019 8 Main Document (1)
Docket Text: Letter from Arnold B. Calmann, Esq. to the Honorable Lois H. Goodman, U.S.M.J. Enclosing Proposed Stipulation and Order Regarding Motion to Dismiss (ECF No. 18 in Civil Action No. 18-14305). (Attachments: # (1) Text of Proposed Order)(CALMANN, ARNOLD)
Mar 11, 2019 7 Order (5)
Docket Text: ORDER SCHEDULING CONFERENCE: Scheduling Conference set for 3/21/2019 10:00 AM in Trenton - Courtroom 7E before Magistrate Judge Lois H. Goodman. Signed by Magistrate Judge Lois H. Goodman on 3/5/2019. (km)
Mar 8, 2019 1 Complaint (13)
Mar 8, 2019 N/A Add and Terminate Judges (0)
Docket Text: Judge Peter G. Sheridan and Magistrate Judge Lois H. Goodman added. (jmh)
Mar 8, 2019 1 Exhibit A (18)
Mar 8, 2019 1 Civil Cover Sheet (4)
Mar 8, 2019 1 L. Civ. R. 11.2 Certification (3)
Mar 8, 2019 2 Corporate Disclosure Statement (aty) (1)
Docket Text: Corporate Disclosure Statement by DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC identifying Bausch Health Companies Inc. as Corporate Parent.. (DENI, WILLIAM)
Mar 8, 2019 3 Corporate Disclosure Statement (aty) (1)
Docket Text: Corporate Disclosure Statement by KAKEN PHARMACEUTICAL CO., LTD.. (DENI, WILLIAM)
Mar 8, 2019 4 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by J. BRUGH LOWER on behalf of DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC (LOWER, J.)
Mar 8, 2019 5 AO120 Patent/Trademark Form (1)
Docket Text: AO120 Patent Form filed. (jmh)
Mar 8, 2019 6 Summons Issued (2)
Docket Text: SUMMONS ISSUED as to MYLAN INC., MYLAN LABORATORIES LTD., MYLAN PHARMACEUTICALS INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (jmh)
Mar 8, 2019 1 Main Document (13)
Docket Text: COMPLAINT against MYLAN INC., MYLAN LABORATORIES LTD., MYLAN PHARMACEUTICALS INC. ( Filing and Admin fee $ 400 receipt number 0312-9484070), filed by VALEANT PHARMACEUTICALS NORTH AMERICA LLC, KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD.. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet, # (3) L. Civ. R. 11.2 Certification)(DENI, WILLIAM)
Menu